Axiom
Phase 3Axiom brings clinical confidence to the earliest stages of drug discovery through human-relevant data and mechanistic AI—so you can focus on developing safer, better medicines.
Founded
2015
Focus
AI / Machine Learning
About
Axiom brings clinical confidence to the earliest stages of drug discovery through human-relevant data and mechanistic AI—so you can focus on developing safer, better medicines.
Funding History
6Total raised: $1.2M
Grant$30KNIGMSAug 18, 2015
Grant$216KNIGMSMay 18, 2015
Grant$220KNIGMSJan 19, 2015
Grant$219KNIDDKSep 17, 2014
Company Info
TypePrivate
Founded2015
LocationSan Francisco, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile